Asa Abeliovich, founder of Prevail and Alector, and now Leal Therapeutics
February 14, 2022 06:36 AM ESTUpdated 07:01 AM
People
Startups

Scoop: Star neu­ro­sci­en­tist Asa Abe­liovich and Or­biMed are team­ing on yet an­oth­er biotech

Jason Mast

Editor

It’s been bare­ly a year since Eli Lil­ly bought his sec­ond com­pa­ny, Pre­vail Ther­a­peu­tics, for $1 bil­lion, but star Co­lum­bia neu­ro­sci­en­tist Asa Abe­liovich is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times